The subsequent binding of anti-Gal Ab to the α-gal epitopes de novo expressed on the tumor cells results in destruction of tumor cells as in xenograft rejection and the targeting of tumor cells and cell membranes to APC. The gene discussed is APC; the disease is neoplasm.